TNF and COVID-19: Studies report either robust activation of the T-cells in critical cases (232) with a high percentage of IFN-γ-producing CTL cells (233) or severe COVID-19 as an immunosuppressive phenotype, exemplified by profound declines in IFNγ- and TNF-producing T cells (225).